Euglycemic diabetic ketoacidosis

Disease1 paper

In silico1

Latest

2

Frontiers in EndocrinologyIn silico19 Sep

Adverse event reporting signals for SGLT-2 inhibitor-metformin combination therapy: a disproportionality analysis of the FAERS database

SGLT2 inhibitors

AHA Scientific Sessions 2025 AbstractResearch3 Nov

Paradoxical Renal Protection after Euglycemic DKA in a CKD Stage 4 Diabetic Patient on Empagliflozin: A Case Report and Mechanistic Insights

ENDO 2025 AbstractReview23 Oct

SUN-590 SGLT2 Inhibitors Being Held In An Inpatient Setting Leading To Higher Rates Of DKA

ADA Scientific Sessions 2025 AbstractHuman trial13 Jun

Integrated Diabetes Care Improves Metabolic Outcomes and Promotes Utilization of Incretin Analogs and Sodium–Glucose Cotransporter Type 2 Inhibitors in Patients with Serious Mental Illness